Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

AMBP Inhibitors

AMBP inhibitors belong to a distinctive chemical class that primarily targets the alpha-1-microglobulin/bikunin precursor (AMBP) protein. The AMBP protein, also known as inter-alpha-trypsin inhibitor (ITI), plays a crucial role in various physiological processes, particularly in modulating inflammation and tissue repair. This class of inhibitors is characterized by their ability to selectively interact with AMBP, impeding its normal functions. AMBP itself is a complex multifunctional glycoprotein composed of multiple protein components, with bikunin being a prominent constituent. Bikunin, in turn, is involved in the inhibition of various proteases, contributing to the regulation of proteolytic activities.

AMBP inhibitors typically possess key molecular features that enable them to bind to specific regions of the AMBP protein, thereby disrupting its interactions and subsequent downstream effects. The development of AMBP inhibitors involves a deep understanding of the molecular interactions between the inhibitor and the target protein, allowing for the design of compounds with enhanced binding affinity and selectivity. Researchers in this field aim to elucidate the intricate biochemical mechanisms underlying the AMBP protein's functions and its involvement in various physiological processes. By selectively inhibiting AMBP, this chemical class holds promise for advancing our understanding of complex biological pathways and may pave the way for novel research directions in the broader field of molecular biology and biochemistry.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Sorafenib can inhibit multiple kinases involved in cell proliferation and angiogenesis, which may indirectly affect AMBP-related pathways.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor that may interfere with AMBP-related pathways through its anti-angiogenic effects.

Vandetanib

443913-73-3sc-220364
sc-220364A
5 mg
50 mg
$167.00
$1353.00
(1)

ZD6474 is a tyrosine kinase inhibitor that can impact EGFR and VEGFR2, potentially affecting AMBP-related pathways.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib inhibits several tyrosine kinases, which can possibly affect the signaling pathways that involve AMBP.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Erlotinib can inhibit EGFR tyrosine kinase, which may indirectly influence AMBP-related pathways.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib can inhibit EGFR, potentially affecting AMBP-related pathways.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Lapatinib can interfere with EGFR and HER2/neu, which may indirectly impact AMBP-related pathways.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Imatinib inhibits BCR-ABL, c-KIT, and PDGFR, which can possibly affect the signaling pathways that involve AMBP.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Pazopanib is a multi-kinase inhibitor that can potentially affect AMBP-related pathways.

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$182.00
$661.00
$1690.00
3
(0)

Lenvatinib can inhibit VEGFR2 tyrosine kinase, possibly affecting AMBP-related pathways.